JOURNAL ARTICLE
Immune checkpoint inhibitor-induced radiation recall myositis.
Published In: Rheumatology, 2023, v. 62, n. 6. P. e191 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Yamamoto, Hirotaka; Taniguchi, Yoshinori 3 of 3
Abstract
The article describes the case of a 70-year-old man with persistent haematuria diagnosed with bladder cancer and was recommended to undergo a total bladder resection but he refused. Topics discussed include the initiation of chemotherapy with gemcitabine and carboplatin to suppress additional tumour progression, the good response of the bladder cancer to avelumab, and the possible diagnosis of immune checkpoint inhibitor (ICI)-induced radiation recall myositis (RRM).
Additional Information
- Source:Rheumatology. 2023/06, Vol. 62, Issue 6, pe191
- Document Type:Case Study
- Subject Area:Health and Medicine
- Publication Date:2023
- ISSN:1462-0324
- DOI:10.1093/rheumatology/keac636
- Accession Number:164066802
Looking to go deeper into this topic? Look for more articles on EBSCOhost.